A new trading day began on Monday, with Tenet Healthcare Corp (NYSE: THC) stock price up 4.00% from the previous day of trading, before settling in for the closing price of $156.13. THC’s price has ranged from $52.08 to $171.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 2.48%. Meanwhile, its annual earnings per share averaged 59.67%. With a float of $92.73 million, this company’s outstanding shares have now reached $99.95 million.
Considering the fact that the conglomerate employs 106500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 18.8%, operating margin of 15.44%, and the pretax margin is 24.38%.
Tenet Healthcare Corp (THC) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Tenet Healthcare Corp is 2.49%, while institutional ownership is 96.33%. The most recent insider transaction that took place on Oct 31 ’24, was worth 623,744. In this transaction EVP, Commercial Ops of this company sold 4,000 shares at a rate of $155.94, taking the stock ownership to the 15,566 shares. Before that another transaction happened on Oct 31 ’24, when Company’s Officer proposed sale 4,000 for $155.93, making the entire transaction worth $623,727.
Tenet Healthcare Corp (THC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 59.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.95% during the next five years compared to 40.40% growth over the previous five years of trading.
Tenet Healthcare Corp (NYSE: THC) Trading Performance Indicators
Here are Tenet Healthcare Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74. Likewise, its price to free cash flow for the trailing twelve months is 6.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 31.26, a number that is poised to hit 2.93 in the next quarter and is forecasted to reach 11.59 in one year’s time.
Technical Analysis of Tenet Healthcare Corp (THC)
Compared to the last year’s volume of 1.21 million, its volume of 1.87 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 79.39%. Additionally, its Average True Range was 6.23.
During the past 100 days, Tenet Healthcare Corp’s (THC) raw stochastic average was set at 79.35%, which indicates a significant decrease from 87.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.84% in the past 14 days, which was higher than the 41.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $159.32, while its 200-day Moving Average is $128.15. Nevertheless, the first resistance level for the watch stands at $165.20 in the near term. At $168.02, the stock is likely to face the second major resistance level. The third major resistance level sits at $172.55. If the price goes on to break the first support level at $157.85, it is likely to go to the next support level at $153.32. Should the price break the second support level, the third support level stands at $150.50.
Tenet Healthcare Corp (NYSE: THC) Key Stats
With a market capitalization of 15.55 billion, the company has a total of 95,097K Shares Outstanding. Currently, annual sales are 20,548 M while annual income is 611,000 K. The company’s previous quarter sales were 5,103 M while its latest quarter income was 259,000 K.
